Back to results
US 11,813,271 B2Granted
Sialic acid compositions for the use of inhibiting and treating coronavirus infection
AssigneeLifeScience AS
InventorJan Remmereit
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of compositions comprising sialic acid to inhibit or treat coronavirus infections, and in particular those caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).
Claims38
A method for treating or inhibiting infection by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), in a human or animal subject, the method comprising:
- administering a composition comprising n-acetylneuraminic acid (NANA) in an effective concentration to the subject under conditions such that infection by SARS-CoV-2 is inhibited or treated.
A method for prophylaxis of infection by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), in a human or animal subject, the method comprising:
- administering a composition comprising n-acetylneuraminic acid (NANA) in an effective concentration to the subject under conditions such that infection by SARS-CoV-2 is inhibited.
Dependencies are inferred from the claim text.